Single antigen flow beads for identification of human leukocyte antigen antibody specificities in hypersensitized patients with chronic renal failure.

Cent Eur J Immunol

Department of Medical Biology and Genetics, Faculty of Medicine, İzmir Katip Çelebi University, İzmir, Turkey; Tissue Typing Laboratory, Izmir Tepecik Education and Research Hospital, İzmir, Turkey.

Published: April 2016

Aims Of This Study: Aims of this study were to identify class I and class II antibodies in highly sensitized patients by flow cytometry single antigen bead (FC-SAB) assay and to evaluate according to donor HLA type in order to increase their kidney transplantation chance.

Material And Methods: We analyzed 60 hypersensitive patients of 351 individuals, who applied to our laboratory for PRA test in November 2013-December 2014. Flow cytometric PRA screening and single antigen bead commercial kits were used for these analyses.

Results: In our study group, 19 (31.7%) of these patients were male while 41 (68.3%) patients were female. The most common acceptable antigens were A*02 (10.11%), HLA-A*23 (10.11%), HLA-B*38 (8.79%) and HLA-DRB1*03 (7.83%) in hypersensitive patients. The highest antibody reactivity on SAB was observed against HLA-A*25, HLA-B*45, HLA-DRB1*04 and HLA-DRB1*08 antigens.

Conclusions: The determination of these acceptable and unacceptable antigens may increase their transplantation chance. Pre-transplant HLA antibody identifications provide prognostic information with respect to the determination of patients who are at increased risk of graft loss.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4829810PMC
http://dx.doi.org/10.5114/ceji.2015.56964DOI Listing

Publication Analysis

Top Keywords

single antigen
12
aims study
8
antigen bead
8
hypersensitive patients
8
patients
7
antigen flow
4
flow beads
4
beads identification
4
identification human
4
human leukocyte
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!